Filter results
24/11/2022
The LAI Challenge seeks innovative solutions in the field of sustained-release injectable drug delivery technologies that may help overcome obstacles in enhancing the efficiency of the healthcare system and the rational use of medicines.
23/11/2022
ROVI updates its strategy in a meeting with shareholders, investors and analysts
04/11/2022
ROVI reports operating revenue growth of 24% and EBITDA growth of 25%
24/10/2022
This new facility will double the production capacity of low molecular weight heparins.
04/10/2022
ROVI, Càrniques Celrà and Grupo Costa announce the construction of a facility at the Industrial Logistics Platform in Fraga (Huesca) to produce compounds of high technological value.
01/08/2022
ROVI has obtained the best ESG score from among the 458 companies evaluated in its pharmaceutical subindustry category.
27/07/2022
ROVI reports operating revenue growth of 31% and net profit growth of 58%
19/07/2022
EIB and ROVI are signing a EUR 50 million loan agreement in Madrid for research, development and innovation.
11/05/2022
ROVI reports operating revenue growth of 57% and net profit growth of 123%